Post Marketing Study to Evaluate the Efficacy and Safety of Micafungin Treatment on Invasive Aspergillosis
Clinical trial NCT02646774 · TERMINATED
Trial details
- NCT number
- NCT02646774
- Sponsor
- Astellas Pharma China, Inc.
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2014-03-01
- Primary completion
- 2015-06-26
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.